By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Nitto Denko Corporation 

300 Frank W Burr Blvd.: Glenpointe Centre East
5th Floor, Suite 66
Teaneck  New Jersey  07666  U.S.A.
Phone: 201-645-4939 Fax: 201-645-4921


SEARCH JOBS


Industry
Medical Device






Company News
Nitto Denko (XETRA: ND5.DE) Signs Partnership Agreement With Daiichi Sankyo 5/10/2016 10:32:05 AM
Nitto Denko (XETRA: ND5.DE) Establishes Nitto BioPharma 1/25/2016 7:50:04 AM
Nitto Denko Corporation (XETRA: ND5.DE)'s ND-L02-S0201:Rnai Anti-Fibrosis Drug For The Treatment Of Liver Fibrosis Granted FDA Fast Track Designation 11/20/2015 8:31:09 AM
Nitto Denko Corporation (XETRA: ND5.DE): New Anti-Fibrosis Drug With Molecular Targeting DDS Starts Phase-1B Dosing For Cirrhosis Patients 10/6/2014 10:22:43 AM
Nitto Denko Corporation (XETRA: ND5.DE): New Anti-fibrosis Drug With Molecular Targeting DDS Completed Phase-1a Dose Escalation 4/22/2014 8:07:17 AM
Nitto Denko Corporation (XETRA: ND5.DE) Obtains US Patent for Antifibrotic Therapies with Molecular Targeting DDS Technology 5/10/2012 11:02:14 AM
Nitto Denko Corporation (XETRA: ND5.DE) to Start-up Prototyping Centre in Singapore's Institute of Materials Research and Engineering (IMRE) 2/23/2011 10:48:48 AM
//-->